- Home
- NOG vs AGIO Comparison
NOG vs AGIO Comparison
Compare NOG & AGIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NOG | AGIO |
|---|---|---|
| Founded | 2006 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.0B |
| IPO Year | 2000 | 2013 |
Fundamental Metrics
Financial Performance| Metric | NOG | AGIO |
|---|---|---|
| Price | $24.95 | $31.88 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 10 |
| Target Price | $30.44 | ★ $46.00 |
| AVG Volume (30 Days) | ★ 1.9M | 878.8K |
| Earning Date | 11-05-2026 | 11-05-2026 |
| Dividend Yield | ★ 7.16% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $2,475,723,000.00 | $43,011,000.00 |
| Revenue This Year | $4.60 | $230.28 |
| Revenue Next Year | $14.65 | $95.06 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 11.23 | N/A |
| 52 Week Low | $17.18 | $22.24 |
| 52 Week High | $31.17 | $46.00 |
Technical Indicators
Market Signals| Indicator | NOG | AGIO |
|---|---|---|
| Relative Strength Index (RSI) | 54.90 | 41.92 |
| Support Level | $22.70 | $26.71 |
| Resistance Level | $25.50 | $35.77 |
| Average True Range (ATR) | 0.69 | 1.17 |
| MACD | 0.13 | -0.13 |
| Stochastic Oscillator | 79.20 | 22.82 |
Price Performance
Historical ComparisonAbout NOG Northern Oil and Gas Inc.
Northern Oil & Gas Inc is an independent energy company engaged in the acquisition, exploration, development, and production of crude oil and natural gas properties. Its principal business is crude oil and natural gas exploration, development, and production. The company's oil and natural gas sales come from three geographic areas in the United States: the Williston Basin (North Dakota and Montana), the Permian Basin (New Mexico and Texas), the Uinta Basin, and the Appalachian Basin (Pennsylvania and Ohio).
About AGIO Agios Pharmaceuticals Inc.
Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236 and others.